Compare Agilent Technologies Inc (A) vs Baidu Inc (BIDU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Baidu Inc — how do they compare? Agilent Technologies Inc trades at $128.7 (market cap $37.04B), while Baidu Inc trades at $117.14 (market cap $38.39B). The key difference: Agilent Technologies Inc and Baidu Inc are close in size by market cap, and Agilent Technologies Inc pays a 0.78% dividend while Baidu Inc pays none. Which is the better fit depends on your goals.
| A | BIDU | |
|---|---|---|
Market Cap | $37.04B | $38.39B |
Sector | Health | Media |
52-Week High | $157.20 | $162.52 |
52-Week Low | $110.24 | $85.86 |
Enterprise Value | $38.59B | $35.05B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
BIDU trades at $112.09, down 1.07% today, with a neutral technical signal and bearish moving averages. Recent earnings show a Q1 2026 miss after two consecutive beats, while revenue declined to $129.08B in 2025. The stock holds a strong buy consensus from analysts with a $177.50 price target, supported by AI-driven optimism including Kunlunxin's potential $50B Hong Kong IPO reported by Reuters on June 28, 2026.
BIDU presents a high-risk, high-reward opportunity with its AI pivot accelerating but facing profitability pressures. The 78.19 P/E ratio suggests premium valuation, yet net margins compressed to 1.02% in 2025. Key risks include regulatory scrutiny and competitive threats, while institutional sentiment remains bullish with 75% buy ratings. Upside hinges on AI monetization offsetting legacy search declines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →
